Usage Restrictions |
In publishing, a citation of the following literature(s) designated by the DEPOSITOR is requested. Development and the characterization of the strain has been published in the following article: Stridh, P Thessen Hedreul, M Beyeen, AD Adzemovic, MZ Laaksonen, H Gillett, A Ockinger, J Marta, M Lassmann, H Becanovic, K Jagodic, M Olsson, T. Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat. PLos One, 2010 Sep 15;5(9):e12716. PMID:20856809. |
Origin |
Inbred Dark Agouti (DA) rats were originally obtained from the Zentralinstitut für Versuchstierzucht (Hannover, Germany) and Piebald Virol Glaxo(PVG) rats from Harlan UK Limited (Blackthorn, UK). Congenic strain was establiesh using a “speed congenic” strategy (Wakeland et al. 1997) with 8 microsatellite markers from the telomeric marker D17Rat8 to D17Rat37, and 95 microsatellite markers outside the congenic regions. In the N7 generation, all 95 background markers were fixed as DA homozygous. One further backcross was performed and chromosome 17 (Eae23) heterozygous rats subsequently intercrossed to produce the congenic strain DA.PVG.1AV1-(D17Rat8-D17Rat37) in 2008. Since then, the strain was kept as inbred. |
References |
Stridh, P Thessen Hedreul, M Beyeen, AD Adzemovic, MZ Laaksonen, H Gillett, A Ockinger, J Marta, M Lassmann, H Becanovic, K Jagodic, M Olsson, T. Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat. PLoS One. 2010 Sep 15;5(9):e12716. PMID:20856809. |